Cargando…
Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2
Activating variants in the receptor tyrosine kinase REarranged during Transfection (RET) cause multiple endocrine neoplasia type 2 (MEN 2), an autosomal dominantly inherited cancer-susceptibility syndrome. The variant c.166C>A, p.Leu56Met in RET was recently reported in two patients with medullar...
Autores principales: | Hansen, Anna Reimer, Borgwardt, Line, Rasmussen, Åse Krogh, Godballe, Christian, Poulsen, Morten Møller, Vieira, Filipe G., Mathiesen, Jes Sloth, Rossing, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672160/ https://www.ncbi.nlm.nih.gov/pubmed/34925234 http://dx.doi.org/10.3389/fendo.2021.764512 |
Ejemplares similares
-
Distribution of RET Mutations in Multiple Endocrine Neoplasia 2 in Denmark 1994–2014: A Nationwide Study
por: Mathiesen, Jes Sloth, et al.
Publicado: (2017) -
Variability in Medullary Thyroid Carcinoma in RET L790F Carriers: A Case Comparison Study of Index Patients
por: Mathiesen, Jes Sloth, et al.
Publicado: (2020) -
Preimplantation Genetic Testing of Multiple Endocrine Neoplasia Type 2A
por: Würgler Hansen, Anders, et al.
Publicado: (2020) -
Completeness of RET testing in patients with medullary thyroid carcinoma in Denmark 1997–2013: a nationwide study
por: Mathiesen, Jes Sloth, et al.
Publicado: (2019) -
Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901–2014: a nationwide study
por: Mathiesen, Jes Sloth, et al.
Publicado: (2018)